{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:06:14Z","timestamp":1793711174562,"version":"4.6.1"},"reference-count":26,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto de Salud Carlos III","award":["PI18_01374"],"award-info":[{"award-number":["PI18_01374"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n","award":["PI18_01374"],"award-info":[{"award-number":["PI18_01374"]}]},{"DOI":"10.13039\/501100004587","name":"European Regional Development Fund \u201cA way to make Europe\u201d","doi-asserted-by":"publisher","award":["PI18_01374"],"award-info":[{"award-number":["PI18_01374"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Congenital myasthenic syndromes (CMSs) and primary mitochondrial myopathies (PMMs) can present with ptosis, external ophthalmoplegia, and limb weakness. Methods: Our method involved the description of three cases of CMS that were initially characterized as probable PMM. Results: All patients were male and presented with ptosis and\/or external ophthalmoplegia at birth, with proximal muscle weakness and fatigue on physical exertion. After normal repetitive nerve stimulation (RNS) studies performed on facial muscles, a muscle biopsy (at a median age of 9) was performed to rule out congenital myopathies. In all three cases, the biopsy findings (COX-negative fibers or respiratory chain defects) pointed to PMM. They were referred to our neuromuscular unit in adulthood to establish a genetic diagnosis. However, at this time, fatigability was evident in the physical exams and RNS in the spinal accessory nerve showed a decremental response in all cases. Targeted genetic studies revealed pathogenic variants in the MUSK, DOK7, and RAPSN genes. The median diagnostic delay was 29 years. Treatment resulted in functional improvement in all cases. Conclusions: Early identification of CMS is essential as medical treatment can provide clear benefits. Its diagnosis can be challenging due to phenotypic overlap with other debilitating disorders. Thus, a high index of suspicion is necessary to guide the diagnostic strategy.<\/jats:p>","DOI":"10.3390\/jcm12093308","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T02:29:22Z","timestamp":1683512962000},"page":"3308","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Delayed Diagnosis of Congenital Myasthenic Syndromes Erroneously Interpreted as Mitochondrial Myopathies"],"prefix":"10.3390","volume":"12","author":[{"given":"Mariana I.","family":"Mu\u00f1oz-Garc\u00eda","sequence":"first","affiliation":[{"name":"Neuromuscular Unit, Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Paz","family":"Guerrero-Molina","sequence":"additional","affiliation":[{"name":"Neuromuscular Unit, Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Pablo","family":"de Fuenmayor-Fern\u00e1ndez de la Hoz","sequence":"additional","affiliation":[{"name":"Neuromuscular Unit, Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8349-715X","authenticated-orcid":false,"given":"Laura","family":"Bermejo-Guerrero","sequence":"additional","affiliation":[{"name":"Neuromuscular Unit, Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4806-9774","authenticated-orcid":false,"given":"Ana","family":"Arteche-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Genetics Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Hern\u00e1ndez-La\u00edn","sequence":"additional","affiliation":[{"name":"Neuropathology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4741-772X","authenticated-orcid":false,"given":"Miguel A.","family":"Mart\u00edn","sequence":"additional","affiliation":[{"name":"Genetics Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain"},{"name":"Spanish Network for Biomedical Research in Rare Diseases (CIBERER), 28041 Madrid, Spain"},{"name":"Mitochondrial and Neuromuscular Diseases Research Group, 12 de Octubre, Hospital Research Institute (imas12), 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5151-988X","authenticated-orcid":false,"given":"Cristina","family":"Dom\u00ednguez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Neuromuscular Unit, Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain"},{"name":"Spanish Network for Biomedical Research in Rare Diseases (CIBERER), 28041 Madrid, Spain"},{"name":"Mitochondrial and Neuromuscular Diseases Research Group, 12 de Octubre, Hospital Research Institute (imas12), 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.nmd.2017.08.003","article-title":"Molecular characterization of congenital myasthenic syndromes in Spain","volume":"27","author":"Benito","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"ref_3","unstructured":"Guptill, J.T., and Sanders, D.B. (2021). Bradley and Daroff\u2019s Neurology in Clinical Practice, Elsevier."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13023-019-1025-5","article-title":"Congenital myasthenic syndromes","volume":"14","author":"Finsterer","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: Pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.nmd.2021.07.400","article-title":"Congenital myasthenic syndromes: Where do we go from here?","volume":"31","author":"Ramdas","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"ref_7","unstructured":"Abicht, A., M\u00fcller, J.S., and Lochm\u00fcller, H. (2022, September 28). Congenital Myasthenic Syndromes Overview. In GeneReviews\u00ae, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/20301347\/."},{"key":"ref_8","unstructured":"Turner, C., Pitceathly, R.D.S., and Schapira, A.H.V. (2021). Bradley and Daroff\u2019s Neurology in Clinical Practice, Elsevier."},{"key":"ref_9","first-page":"31","article-title":"Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK","volume":"24","author":"Dusl","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"ref_10","first-page":"405","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Anesthesia Analg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/CND.0000000000000277","article-title":"Congenital Ophthalmoplegia and Late-Onset Limb Weakness Caused by MUSK Mutations","volume":"21","author":"Ostos","year":"2020","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-510X(98)00263-9","article-title":"Myophosphorylase deficiency associated with a defect in complex I of the mitochondrial respiratory chain","volume":"161","author":"Rubio","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ana.21408","article-title":"Dok-7 myasthenia: Phenotypic and molecular genetic studies in 16 patients","volume":"64","author":"Selcen","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nmd.2015.10.013","article-title":"Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations","volume":"26","author":"Benito","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.WNL.0000085865.55513.AE","article-title":"Rapsyn mutations in hereditary myasthenia: Distinct early- and late-onset phenotypes","volume":"61","author":"Burke","year":"2003","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/WCO.0000000000000736","article-title":"The congenital myasthenic syndromes: Expanding genetic and phenotypic spectrums and refining treatment strategies","volume":"32","author":"Vanhaesebrouck","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2012.06779.x","article-title":"DOK7 congenital myasthenic syndrome","volume":"1275","author":"Palace","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/hmg\/ddaa116","article-title":"Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia","volume":"29","author":"Webster","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1073\/pnas.1524272113","article-title":"Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease","volume":"113","author":"Khan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/CND.0000000000000398","article-title":"Life-Long Steroid Responsive Familial Myopathy with Docking Protein 7 Mutation","volume":"24","author":"Oh","year":"2022","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.1250744","article-title":"DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction","volume":"345","author":"Arimura","year":"2014","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41586-021-03672-3","article-title":"Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia","volume":"595","author":"Oury","year":"2021","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.nmd.2020.10.002","article-title":"Electrophysiological study of neuromuscular junction in congenital myasthenic syndromes, congenital myopathies, and chronic progressive external ophthalmoplegia","volume":"30","author":"Caldas","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/S0012162206000284","article-title":"Decreased activities of mitochondrial respiratory chain complexes in non-mitochondrial respiratory chain diseases","volume":"48","author":"Mbbs","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nmd.2014.11.017","article-title":"Delayed diagnosis of congenital myasthenia due to associated mitochondrial enzyme defect","volume":"25","author":"Guo","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bermejo-Guerrero, L., Hoz, C.P.d.F.-F.d.l., Guerrero-Molina, M.P., Mart\u00edn-Jim\u00e9nez, P., Bl\u00e1zquez, A., Serrano-Lorenzo, P., Lora, D., Morales-Conejo, M., Gonz\u00e1lez-Mart\u00ednez, I., and L\u00f3pez-Jim\u00e9nez, E.A. (2023). Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome. J. Clin. Med., 12.","DOI":"10.3390\/jcm12062435"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/9\/3308\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:30:15Z","timestamp":1760124615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/9\/3308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["jcm12093308"],"URL":"https:\/\/doi.org\/10.3390\/jcm12093308","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]}}}